Chromosomal translocation T(8,21) in acute myeloid leukemia of children: Prognostic value of additional karyotype abnormalities

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 6, 2009, Pages 9-16

  Fleishman, E V ^a   Sokova, O I ^a   Popa, A V ^a   Shneider, M M ^a   Kirichenko, O P ^a   Konstantinova, E V ^a   Metelkova, N F ^a  

^a NONE

Author keywords

Acute myeloid leukemia; Children; Chromosomal translocation; Karyotype abnormalities

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHROMOSOME 21; CHROMOSOME 8; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GENE TRANSLOCATION; GENETICS; HUMAN; KARYOTYPING; MALE; MORTALITY; PRESCHOOL CHILD; PROGNOSIS; RUSSIAN FEDERATION; SURVIVAL RATE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; FOLLOW-UP STUDIES; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; PROGNOSIS; RUSSIA; SURVIVAL RATE; TRANSLOCATION, GENETIC;

EID: 84876544858     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rowley J. D. Identificatioln of translocation with quinacrine fluorescence in a patient with acute leukemia. Ann. Genet. 1973; 16: 109-112.
2. Ferrara F, Del Vecchio L. Acute myeloid leukemia with t(8:21)/ AMLl/ETO: a distinct biological and clinical entity. Haemato-logica2002; 87: 306-319. (Pubitemid 34212448)
3. Arber D. A., Brunning R. D., Le Beau M. M. et al. Acute Myeloid Leukemia and Related Precursor Neoplasms. In: WHO Classification of tumors of hematopoietic and lymphoid tissues. IARC Press. Lyon, 2008: 109-147.
4. Grimwade D., Walker H., Oliver F. et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML10 trial. Blood 1998; 92: 2322-2333. (Pubitemid 28452973)
5. Byrd J. C, Mrozek K., Dodge R. C. et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse and overall survival in adult patients with de novo acute myeloid leukemia: results from GALB 8461. Blood 2002; 100: 4325-4336. (Pubitemid 35429670)
6. Rubnitz J- E., Raimondi S. C.,Halbert A. R.etal. Characteristics and outcome of t(8; 2l)-positive childhood acute myeloid leukemia: single institution's experience. Leukemia 2002; 16: 2072-2077. (Pubitemid 35203450)
7. Kaspers G. I. L, Creutzig U. Pediatric acute myeloid leukemia: international progress and future directions. Leukemia 2005; 19: 2025-2029. (Pubitemid 41741594)
8. Rubnitz J. E., Gibson B., Smith F. O. Acute myeloid leukemia. Pediatr. Clin. N. Am. 2008; 55: 21-51. (Pubitemid 351181320)
9. Heim S., Mitelman F. Cancer cytogenetics. 2-nd ed. Chichester: Wiley-Liss; 1995.
10. Hasle H., Ahnzo T., Auvrignon A. et al. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood 2007; 109: 4641-4647. (Pubitemid 46827753)
11. Shaffer L. G., Tommerup N., eds. ISCN-2005: An international system for human cytogenetic nomenclature. Basel; 2005.
12. Stark B., Jeison M., Glazer-Gabay L. et al. Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukemia: report from referral center of Israel. Br. J. Haematol. 2004; 126: 320-337 (Pubitemid 39005712)
13. Lie S. O., Abrahamsson J., Clausen N. et al. Long-term results in children with AML: NOPHO-AML Study Group - report of three consecutive trials. Leukemia 2005; 19: 2090-2100. (Pubitemid 41741601)
14. Smith F. O., Alonio T. A., Gerbing R. B. et al. Long-term results of children with acute myeloid leukemia: report of three consecutive phase II trials by the Children Cancer Group: CCG 251. CCG 213 and CCG 2891. Leukemia 2005; 19: 2054-2062. (Pubitemid 41741597)
15. Tomizawa D., Tabuchi K., Kinoshita A. et al. Repetitive cycles of high-dose cytorabine arc effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. Pediatr. Blood Cancer 2007; 49: 127-132. (Pubitemid 47041100)
16. .Slovak: M. L, Kopecku K. J., Cassileth P. A. et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia. Blood 2000; 96: 4075-4083.
17. Harrison C, Moorman A. V., Hills R. K. et al. Cytogenetics of childhood AML from UK Medical Research Council treatment trials AML10 and 12. Am. Soc. Hematol. 45-th Meeting: Program and Abstracts (Abstr. 133). Blood 2003; 102 (a): 98a.
18. Schlenk R. F, BennerA., KraulerJ. et al. Inividual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German acute myeloid leukemia Intergroup. J. Clin. Oncol. 2004; 22: 3741-3750. (Pubitemid 41102131)
19. Haferlach T., Bennett J. M., Loffler H. et al. Acute myeloid leukemia with translocation (8:21). Cytomorhology, dysplasia and prognostic factors in 41 cases. Leukemia and Lymphoma 1996; 23: 227-234. (Pubitemid 27029335)